Design and characterization of dual drug delivery based on in-situ assembled PVA/PAN core-shell nanofibers for wound dressing application.
Acrylic Resins
/ chemistry
Bandages
Cell Adhesion
/ drug effects
Cell Death
/ drug effects
Cross-Linking Reagents
/ chemistry
Diclofenac
/ pharmacology
Drug Delivery Systems
Drug Liberation
Nanofibers
/ chemistry
Photoelectron Spectroscopy
Polyvinyl Alcohol
/ chemistry
Spectroscopy, Fourier Transform Infrared
Temperature
Thermogravimetry
Wounds and Injuries
/ drug therapy
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
02 09 2019
02 09 2019
Historique:
received:
05
04
2019
accepted:
09
08
2019
entrez:
4
9
2019
pubmed:
4
9
2019
medline:
24
10
2020
Statut:
epublish
Résumé
Core-shell nanofibers with the ability to carry multiple drugs are attracting the attention to develop appropriate drug delivery systems for wounds dressing applications. In this study, biocompatible core-shell nanofibers have been designed as a promising dual-drug carrier with the capability of delivering both water-soluble and organic solvent-soluble drugs simultaneously. With the aim of fabricating the core-shell nanofibers, the dipping method has been employed. For this propose, core nanofibers made from polyvinyl alcohol (PVA) were immersed in various concentrations of polyacrylonitrile (PAN) and cross-linked by dipping into ethanol. Diclofenac sodium salt (DSs) and gentamicin sulfate (GENs) have been loaded into the core and shell nanofibers as models of the drug, respectively. The morphology study of core-shell nanofibers showed that the concentrations between 1% w/w up to 2% w/w PAN/GENs, with deep penetration into the internal layers of PAV/DSs nanofibers could lead to the core-shell structure. The cytotoxicity results showed the competency of designed core-shell nanofibers for wound dressing application. Also, the release profile exhibits the controllable behavior of drug release.
Identifiants
pubmed: 31477774
doi: 10.1038/s41598-019-49132-x
pii: 10.1038/s41598-019-49132-x
pmc: PMC6718412
doi:
Substances chimiques
Acrylic Resins
0
Cross-Linking Reagents
0
Diclofenac
144O8QL0L1
polyacrylonitrile
25014-41-9
Polyvinyl Alcohol
9002-89-5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
12640Références
RSC Adv. 2018 Sep 21;8(57):32695-32706
pubmed: 35547714
Small. 2018 May;14(22):e1704379
pubmed: 29709108
Int J Pharm. 2017 Oct 5;531(1):101-107
pubmed: 28830784
RSC Adv. 2018 Mar 23;8(21):11543-11550
pubmed: 35542777
J Control Release. 2014 Jul 10;185:12-21
pubmed: 24768792
Adv Drug Deliv Rev. 2008 Aug 17;60(11):1278-1288
pubmed: 18514969
Sci China Life Sci. 2018 Apr;61(4):427-435
pubmed: 29656338
Acta Biomater. 2012 Feb;8(2):763-71
pubmed: 22100346
Biomacromolecules. 2012 Apr 9;13(4):952-62
pubmed: 22401557
Mol Pharm. 2013 Dec 2;10(12):4509-26
pubmed: 24191694
Appl Microbiol Biotechnol. 2018 Aug;102(16):7171-7181
pubmed: 29948109
Int J Pharm. 2011 Apr 15;408(1-2):200-7
pubmed: 21291969
Chem Soc Rev. 2012 May 7;41(9):3679-98
pubmed: 22441299
ACS Appl Mater Interfaces. 2017 Jan 18;9(2):1840-1846
pubmed: 28001349
Nanomaterials (Basel). 2018 Jun 25;8(7):
pubmed: 29941857
RSC Adv. 2018 Apr 24;8(28):15558-15566
pubmed: 35539465
Nanomaterials (Basel). 2018 Aug 22;8(9):
pubmed: 30131479
Nanotechnology. 2009 Nov 18;20(46):465603
pubmed: 19847030
Arch Orthop Trauma Surg. 2012 Jun;132(6):897-903
pubmed: 22373914
Curr Mol Biol Rep. 2015;1(3):132-140
pubmed: 26618105
J Funct Biomater. 2018 May 18;9(2):
pubmed: 29783681